ZURA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.80%

Insider Buying (Last 12 Months): $1,034,998.13

Insider Selling (Last 12 Months): $0.00

Zura Bio Insider Trading History Chart

Zura Bio Share Price & Price History

^$4.41

▲ +0.79 (21.82%)

As of 04/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

Zura Bio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/22/2024	Amit Munshi	Director	Buy	159,744	$3.13	$499,998.72	777,384
4/22/2024	Kiran Nistala	EVP	Buy	3,195	$3.13	$10,000.35	3,195
4/22/2024	Michael Howell	Insider	Buy	7,987	$3.13	$24,999.31	7,987
6/5/2023	Amit Munshi	Director	Buy	117,647	$4.25	$499,999.75	617,640

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

SEC Filings (Institutional Ownership Changes) for Zura Bio (NASDAQ:ZURA)

61.14% of Zura Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Zura Bio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/15/2024	Forefront Analytics LLC	21,229	$99K	0.0%	+46.8%	0.049%
2/13/2024	Armistice Capital LLC	1,824,000	$8.52M	0.1%	+15.4%	4.233%
11/15/2023	Armistice Capital LLC	1,580,000	$10.43M	0.2%	+66.3%	3.667%
11/14/2023	Lynx1 Capital Management LP	9,917	$65K	0.0%	N/A	0.023%
11/13/2023	Eisler Capital US LLC	100,000	$0.66M	0.0%	N/A	0.232%
11/13/2023	Silverarc Capital Management LLC	404,040	$2.67M	0.8%	+152.5%	0.938%
11/8/2023	Forefront Analytics LLC	14,464	$95K	0.1%	N/A	0.034%
10/24/2023	Bank of New York Mellon Corp	33,973	$0.22M	0.0%	N/A	0.079%
10/24/2023	Raymond James & Associates	77,356	$0.51M	0.0%	+14.0%	0.180%
8/15/2023	Silverarc Capital Management LLC	160,000	$1.31M	0.4%	N/A	0.591%
8/15/2023	Suvretta Capital Management LLC	2,850,000	$23.37M	1.2%	N/A	10.536%
8/14/2023	Great Point Partners LLC	3,295,000	$27.02M	5.3%	N/A	12.181%
8/14/2023	Deep Track Capital LP	2,523,000	$20.69M	1.0%	N/A	5.855%
8/10/2023	Monashee Investment Management LLC	240,000	$1.97M	0.5%	N/A	0.887%
8/4/2023	American International Group Inc.	3,649	$30K	0.0%	N/A	0.013%
7/25/2023	Raymond James & Associates	67,875	$0.56M	0.0%	N/A	0.251%

Data available starting January 2016

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops Tibulizumab, an IgG-scFv bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes IL-17A and BAFF, which is in Phase 2 clinical trial development; ZB-168, a monoclonal antibody that binds and neutralizes the IL-7 receptor chain that impact on diseases driven by IL7 and thymic stromal lymphopoietin immune pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in Henderson, Nevada.

Today's Range

Now: $4.41

$3.68

$4.83

50 Day Range

MA: $3.19

$2.05

$4.41

52 Week Range

Now: $4.41

$2.00

$14.00

Volume

895,952 shs

Average Volume

257,676 shs

Market Capitalization

$190.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.55

Who are the company insiders with the largest holdings of Zura Bio?: Zura Bio's top insider shareholders include:
Amit Munshi (Director)
Michael Howell (Insider)
Kiran Nistala (EVP)
Learn More about top insider investors at Zura Bio.